Market Place
Sourcing Support
Seelos doses first subject in ALS basket trial in Australia
19 Jul 2022 //
CLINICALTRIALSARENA
Seelos Receives FDA May Proceed Notice to Initiate a Ph IIb/III Trial SLS-005
10 Aug 2020 //
PRNEWSWIRE
Seelos Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005
21 Jul 2020 //
PRNEWSWIRE
Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics
19 Feb 2019 //
PRESS RELEASE
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
19 Feb 2019 //
GLOBNEWSWIRE
Bioblast Pharma Collaborates to Evaluate Trehalose for Sanfilippo Syndrome
14 Feb 2019 //
NASDAQ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.